-
1
المصدر: Front Cell Dev Biol.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::d12db7ff0cc277070fded33a2ed13d65
-
2
المؤلفون: Forster, M, Chaikuad, A, Bauer, SM, Holstein, J, Robers, MB, Corona, CR, Gehringer, M, Pfaffenrot, E, Ghoreschi, K, Knapp, S, Laufer, SA
المصدر: Cell Chemical Biology, 23 (11)
Cell Chemical Biologyمصطلحات موضوعية: Binding Sites, T-Lymphocytes, chemical probe, Janus Kinase 3, Brief Communication, kinome selectivity, Molecular Docking Simulation, covalent reversible inhibitor, Drug Discovery, Janus kinases, Humans, JAK3, Protein Kinase Inhibitors, Signal Transduction
وصف الملف: application/application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f7ee3c3020c7581505aea9d568fe0541
-
3دورية أكاديمية
المؤلفون: Němec V; Institute for Pharmaceutical Chemistry, Structural Genomics Consortium, Johann Wolfgang Goethe-University, Max-von-Laue-Strasse 9, Frankfurt am Main, 60438, Germany.; Department of Chemistry, Masaryk University, Brno 625 00, Czech Republic., Remeš M; Department of Chemistry, Masaryk University, Brno 625 00, Czech Republic., Beňovský P; Department of Chemistry, Masaryk University, Brno 625 00, Czech Republic., Böck MC; Department of Chemistry, Masaryk University, Brno 625 00, Czech Republic., Šranková E; Department of Chemistry, Masaryk University, Brno 625 00, Czech Republic., Wong JF; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K., Cros J; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K., Williams E; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K., Tse LH; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K., Smil D; Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, Toronto, Ontario M5G 0A3, Canada., Ensan D; Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, Toronto, Ontario M5G 0A3, Canada., Isaac MB; Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, Toronto, Ontario M5G 0A3, Canada., Al-Awar R; Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, Toronto, Ontario M5G 0A3, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Gomolková R; Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, 602 00 Brno, Czech Republic., Ursachi VC; Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, 602 00 Brno, Czech Republic., Fafílek B; Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, 602 00 Brno, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, 602 00 Brno, Czech Republic., Kahounová Z; Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 612 00 Brno Czech Republic., Víchová R; Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 612 00 Brno Czech Republic., Vacek O; International Clinical Research Center, St. Anne's University Hospital, 602 00 Brno, Czech Republic.; Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 612 00 Brno Czech Republic., Berger BT; Institute for Pharmaceutical Chemistry, Structural Genomics Consortium, Johann Wolfgang Goethe-University, Max-von-Laue-Strasse 9, Frankfurt am Main, 60438, Germany., Wells CI; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States., Corona CR; Promega Corporation, Madison, Wisconsin 53716, United States., Vasta JD; Promega Corporation, Madison, Wisconsin 53716, United States., Robers MB; Promega Corporation, Madison, Wisconsin 53716, United States., Krejci P; Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, 602 00 Brno, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, 602 00 Brno, Czech Republic., Souček K; International Clinical Research Center, St. Anne's University Hospital, 602 00 Brno, Czech Republic.; Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 612 00 Brno Czech Republic., Bullock AN; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K., Knapp S; Institute for Pharmaceutical Chemistry, Structural Genomics Consortium, Johann Wolfgang Goethe-University, Max-von-Laue-Strasse 9, Frankfurt am Main, 60438, Germany., Paruch K; Department of Chemistry, Masaryk University, Brno 625 00, Czech Republic.; Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, 602 00 Brno, Czech Republic.
المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Aug 08; Vol. 67 (15), pp. 12632-12659. Date of Electronic Publication: 2024 Jul 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
مواضيع طبية MeSH: Activin Receptors, Type II*/metabolism , Activin Receptors, Type II*/antagonists & inhibitors, Animals ; Humans ; Mice ; Activin Receptors, Type I/antagonists & inhibitors ; Activin Receptors, Type I/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/chemistry ; Structure-Activity Relationship ; Signal Transduction/drug effects ; Drug Discovery ; Molecular Probes/chemistry ; Bone Morphogenetic Proteins/metabolism ; Pyrazoles/chemistry ; Pyrazoles/pharmacology ; Pyrazoles/chemical synthesis
-
4دورية أكاديمية
المؤلفون: Dopfer J; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany.; Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438, Frankfurt am Main, Germany., Vasta JD; Promega Corporation, Madison, WI, USA., Müller S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany.; Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438, Frankfurt am Main, Germany., Knapp S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany.; Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK)/German Cancer Research Center (DKFZ), DKTK Site Frankfurt-Mainz, 69120, Heidelberg, Germany., Robers MB; Promega Corporation, Madison, WI, USA., Schwalm MP; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany. schwalm@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438, Frankfurt am Main, Germany. schwalm@pharmchem.uni-frankfurt.de.; German Cancer Consortium (DKTK)/German Cancer Research Center (DKFZ), DKTK Site Frankfurt-Mainz, 69120, Heidelberg, Germany. schwalm@pharmchem.uni-frankfurt.de.
المصدر: Nature communications [Nat Commun] 2024 Jul 05; Vol. 15 (1), pp. 5646. Date of Electronic Publication: 2024 Jul 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
-
5دورية أكاديمية
المؤلفون: Capener JL; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Vasta JD; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Katis VL; ARUK Oxford Drug Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Michaud A; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Beck MT; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Daglish SCD; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Cohen-Kedar S; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Barda ES; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Howell S; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Dotan I; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Robers MB; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Axtman AD; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Bashore FM; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 13. Date of Electronic Publication: 2024 Jun 13.
نوع المنشور: Journal Article; Preprint
بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
-
6دورية أكاديمية
المؤلفون: Ku AF; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Sharma KL; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Ta HM; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA., Sutton CM; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Bohren KM; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Wang Y; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Chamakuri S; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Chen R; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Hakenjos JM; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Jimmidi R; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Kent K; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Li F; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA., Li JY; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Ma L; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Madasu C; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Palaniappan M; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Palmer SS; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Qin X; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Robers MB; Promega Corporation, Madison, WI 53711, USA., Sankaran B; Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA., Tan Z; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA., Vasquez YM; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Wang J; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Wilkinson J; Promega Corporation, Madison, WI 53711, USA., Yu Z; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Ye Q; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Young DW; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA., Teng M; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA., Kim C; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA., Matzuk MM; Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
المصدر: Science (New York, N.Y.) [Science] 2024 May 24; Vol. 384 (6698), pp. 885-890. Date of Electronic Publication: 2024 May 23.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
مواضيع طبية MeSH: Contraceptive Agents, Male*/chemistry , Contraceptive Agents, Male*/pharmacology , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/chemistry , Protein Serine-Threonine Kinases*/antagonists & inhibitors , Protein Serine-Threonine Kinases*/chemistry , Small Molecule Libraries*/chemistry , Small Molecule Libraries*/pharmacology , Contraception*/methods, Animals ; Humans ; Male ; Mice ; Blood-Testis Barrier/metabolism ; Testis/drug effects ; Structure-Activity Relationship
-
7دورية أكاديمية
المؤلفون: Sugawara T; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Nevedomskaya E; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Heller S; Nuvisan ICB GmbH, Berlin, Germany., Böhme A; Nuvisan ICB GmbH, Berlin, Germany., Lesche R; Nuvisan ICB GmbH, Berlin, Germany., von Ahsen O; Nuvisan ICB GmbH, Berlin, Germany., Grünewald S; Nuvisan ICB GmbH, Berlin, Germany., Nguyen HM; Department of Urology, University of Washington, Seattle, WA, USA., Corey E; Department of Urology, University of Washington, Seattle, WA, USA., Baumgart SJ; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Georgi V; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Pütter V; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Fernández-Montalván A; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Vasta JD; Promega Corporation, Madison, WI, USA., Robers MB; Promega Corporation, Madison, WI, USA., Politz O; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Mumberg D; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany., Haendler B; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.
المصدر: Molecular oncology [Mol Oncol] 2024 Mar; Vol. 18 (3), pp. 726-742. Date of Electronic Publication: 2024 Jan 15.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Proto-Oncogene Proteins c-akt*/metabolism , Prostatic Neoplasms*/genetics, Male ; Humans ; Aged ; Receptors, Androgen/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Caspase 3 ; Androgens ; TOR Serine-Threonine Kinases/metabolism ; Cell Proliferation ; Apoptosis ; Cell Line, Tumor
-
8دورية أكاديمية
المؤلفون: Teske KA; Promega Corporation, Research & Development, Madison, WI 53711, USA., Corona C; Promega Corporation, Research & Development, San Luis Obispo, CA 93401, USA., Wilkinson J; Promega Corporation, Research & Development, Madison, WI 53711, USA., Mamott D; Promega Corporation, Research & Development, Madison, WI 53711, USA., Good DA; Promega Corporation, Research & Development, San Luis Obispo, CA 93401, USA., Zambrano D; Promega Corporation, Research & Development, San Luis Obispo, CA 93401, USA., Lazar DF; Promega Corporation, Research & Development, Madison, WI 53711, USA., Cali JJ; Promega Corporation, Research & Development, Madison, WI 53711, USA., Robers MB; Promega Corporation, Research & Development, Madison, WI 53711, USA. Electronic address: matt.robers@promega.com., O'Brien MA; Promega Corporation, Research & Development, Madison, WI 53711, USA. Electronic address: martha.obrien@promega.com.
المصدر: Cell chemical biology [Cell Chem Biol] 2024 Feb 15; Vol. 31 (2), pp. 349-360.e6. Date of Electronic Publication: 2023 Oct 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE
مواضيع طبية MeSH: Inflammasomes*/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism, Humans ; Cytokines/metabolism ; Interleukin-1beta/metabolism
-
9دورية أكاديمية
المؤلفون: Vasta JD; Promega Corporation, Madison, WI, USA., Michaud A; Promega Corporation, Madison, WI, USA., Aaron Crapster J; Vibliome Therapeutics LLC, Bozeman, MT, USA., Robers MB; Promega Corporation, Madison, WI, USA. Matt.Robers@promega.com.
المصدر: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2797, pp. 287-297.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
مواضيع طبية MeSH: Proto-Oncogene Proteins c-raf*/metabolism , Mitogen-Activated Protein Kinases*/metabolism, Humans ; Protein Subunits ; Signal Transduction
-
10دورية أكاديمية
المؤلفون: Vasta JD; Promega Corporation, Madison, WI, USA., Michaud A; Promega Corporation, Madison, WI, USA., Zimprich CA; Promega Corporation, Madison, WI, USA., Beck MT; Promega Corporation, Madison, WI, USA., Swiatnicki MR; Promega Corporation, Madison, WI, USA., Zegzouti H; Promega Corporation, Madison, WI, USA., Thomas MR; Promega Corporation, Madison, WI, USA., Wilkinson J; Promega Corporation, Madison, WI, USA., Crapster JA; Vibliome Therapeutics LLC, Bozeman, MT, USA. Electronic address: aaron.crapster@vibliome.com., Robers MB; Promega Corporation, Madison, WI, USA. Electronic address: matt.robers@promega.com.
المصدر: Cell chemical biology [Cell Chem Biol] 2023 Nov 16; Vol. 30 (11), pp. 1354-1365.e6. Date of Electronic Publication: 2023 Aug 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE
مواضيع طبية MeSH: Proto-Oncogene Proteins B-raf*/genetics , Proto-Oncogene Proteins B-raf*/metabolism , Signal Transduction*, Humans ; Protein Subunits/metabolism ; Cell Line, Tumor ; Protein Kinase Inhibitors/pharmacology ; Mutation ; MAP Kinase Signaling System